$SMMT
Summit Therapeutics Inc. Stock $smmt

$smmt Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000159929820000043 Filed on November 16, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q4
Revenue	$185.0K	$181.0K	$120.0K
YoY Change	54.17%	22.3%	-82.35%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.802M	$6.846M	$4.370M
YoY Change	32.77%	470.5%	-6.02%
% of Gross Profit
Research & Development	$12.30M	$13.73M	$7.220M
YoY Change	70.36%	37.94%	-11.95%
% of Gross Profit
Depreciation & Amortization	$458.0K	$397.0K	$360.0K
YoY Change	27.22%	16.76%	0.0%
% of Gross Profit
Operating Expenses	$13.73M	$21.43M	$7.820M
YoY Change	75.63%	69.63%	-21.96%
Operating Profit		-$16.94M
YoY Change		173.68%
Interest Expense	$54.00K		-$60.00K
YoY Change	-190.0%		0.0%
% of Operating Profit
Other Income/Expense, Net	-$67.00K	-$858.0K
YoY Change		1044.0%
Pretax Income	-$13.56M	-$17.80M	-$7.760M
YoY Change	74.77%	184.1%	-17.53%
Income Tax	-$120.0K	-$56.00K	-$730.0K
% Of Pretax Income
Net Earnings	-$13.44M	-$17.74M	-$7.030M
YoY Change	91.21%	178.28%	-13.53%
Net Earnings / Revenue	-7265.95%	-9802.76%	-5858.33%
Basic Earnings Per Share		-$0.26
Diluted Earnings Per Share	-$175.9K	-$0.26	-$43.80K
COMMON SHARES
Basic Shares Outstanding	82.26M shares	67.23M shares
Diluted Shares Outstanding		67.23M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.42M	$21.27M	$13.60M
YoY Change	388.36%	1.92%	4.29%
Cash & Equivalents	$66.42M	$21.30M	$63.84M
Short-Term Investments
Other Short-Term Assets	$1.523M	$1.667M	$1.399M
YoY Change	8.86%		-89.09%
Inventory
Prepaid Expenses	$9.547M	$7.141M	$8.762M
Receivables	$331.0K	$4.080M	$541.0K
Other Receivables	$9.856M	$7.919M	$3.670M
Total Short-Term Assets	$87.67M	$42.08M	$79.63M
YoY Change	10.1%	20.39%	152.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$725.0K	$724.0K	$518.0K
YoY Change	39.96%	-47.15%	-17.78%
Goodwill	$2.030M	$2.335M	$1.961M
YoY Change	3.52%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$14.82M	$14.79M	$16.62M
YoY Change	-10.81%	9.78%	25.24%
TOTAL ASSETS
Total Short-Term Assets	$87.67M	$42.08M	$79.63M
Total Long-Term Assets	$14.82M	$14.79M	$16.62M
Total Assets	$102.5M	$56.87M	$96.25M
YoY Change	6.49%	17.44%	114.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.140M	$2.493M	$4.471M
YoY Change	37.33%	-61.65%	-15.8%
Accrued Expenses	$3.278M	$4.398M	$5.739M
YoY Change	-42.88%
Deferred Revenue	$8.370M	$7.111M	$2.615M
YoY Change	220.08%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$360.0K
YoY Change
Total Short-Term Liabilities	$19.89M	$14.74M	$13.77M
YoY Change	44.48%	46.25%	11.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$400.0K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$2.511M	$2.277M	$2.703M
YoY Change	-7.1%	-10.35%	-1.35%
Total Long-Term Liabilities	$2.511M	$2.277M	$2.703M
YoY Change	-7.1%	-24.85%	-1.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.89M	$14.74M	$13.77M
Total Long-Term Liabilities	$2.511M	$2.277M	$2.703M
Total Liabilities	$23.05M	$20.00M	$17.39M
YoY Change	32.56%	35.9%	3.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$210.9M	-$199.2M	-$158.2M
YoY Change	33.3%
Common Stock	$826.0K	$672.0K	$672.0K
YoY Change	22.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$79.45M	$38.55M	$78.86M
YoY Change
Total Liabilities & Shareholders Equity	$102.5M	$56.87M	$96.25M
YoY Change	6.49%	17.44%	114.7%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q4
OPERATING ACTIVITIES
Net Income	-$13.44M	-$17.74M	-$7.030M
YoY Change	91.21%	178.28%	-13.53%
Depreciation, Depletion And Amortization	$458.0K	$397.0K	$360.0K
YoY Change	27.22%	16.76%	0.0%
Cash From Operating Activities	-$7.971M	-$16.65M	-$6.280M
YoY Change	26.93%	99.87%	46.05%
INVESTING ACTIVITIES
Capital Expenditures	-$50.00K	-$44.00K	-$10.00K
YoY Change	400.0%	-80.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change
Cash From Investing Activities	-$50.00K	-$44.00K	-$10.00K
YoY Change	400.0%	-80.0%	0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.55M	0.000	-90.00K
YoY Change	-56264.44%	-100.0%	12.5%
NET CHANGE
Cash From Operating Activities	-7.971M	-16.65M	-6.280M
Cash From Investing Activities	-50.00K	-44.00K	-10.00K
Cash From Financing Activities	50.55M	0.000	-90.00K
Net Change In Cash	42.53M	-16.69M	-6.380M
YoY Change	-766.57%	93.21%	45.33%
FREE CASH FLOW
Cash From Operating Activities	-$7.971M	-$16.65M	-$6.280M
Capital Expenditures	-$50.00K	-$44.00K	-$10.00K
Free Cash Flow	-$7.921M	-$16.61M	-$6.270M
YoY Change	26.33%	104.75%	45.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001599298
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36866
	dei	Entity Registrant Name EntityRegistrantName	Summit Therapeutics Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1979717
	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Broadway, 14th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Cambridge
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02142
	dei	City Area Code CityAreaCode	617
	dei	Local Phone Number LocalPhoneNumber	514-7149
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	SMMT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82260004	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21270000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63842000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4080000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	541000	USD
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7141000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8762000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1667000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1399000	USD
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7919000	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5084000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	42077000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	79628000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	724000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	518000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	628000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1021000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	2335000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	2392000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11101000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13120000	USD
CY2020Q3	us-gaap	Assets Assets	56865000	USD
CY2019Q4	us-gaap	Assets Assets	96679000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2493000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4471000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4398000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5739000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	354000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	366000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	386000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	471000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	7111000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2615000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	105000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14742000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13767000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	715000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	493000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	422000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2277000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2703000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2108000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2057000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	20004000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	19442000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67231903	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67231903	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67178054	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67178054	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	672000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	672000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	242395000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	241204000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7032000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4720000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199174000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-159919000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	36861000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	77237000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56865000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	96679000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	181000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	148000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	675000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	795000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14387000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9951000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40979000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32586000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7460000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2683000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13430000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7917000	USD
CY2020Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	859000	USD
CY2019Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	859000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	22706000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	12634000	USD
	us-gaap	Operating Expenses OperatingExpenses	55268000	USD
	us-gaap	Operating Expenses OperatingExpenses	40503000	USD
CY2020Q3	us-gaap	Other Operating Income OtherOperatingIncome	4309000	USD
CY2019Q3	us-gaap	Other Operating Income OtherOperatingIncome	6296000	USD
	us-gaap	Other Operating Income OtherOperatingIncome	14949000	USD
	us-gaap	Other Operating Income OtherOperatingIncome	19881000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18216000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6190000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-39644000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19827000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	416000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-75000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	296000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-231000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17800000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6265000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39348000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20058000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-99000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-93000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-13000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17701000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6376000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39255000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20045000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2255000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1255000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2312000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1299000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15446000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7631000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-41567000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21344000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	51946000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	361000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2255000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17701000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	36861000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	77237000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1188000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2312000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39255000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	36861000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	43564000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	244000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1255000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6376000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	36177000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	32170000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24501000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	848000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1299000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20045000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	36177000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39255000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20045000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-101000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	296000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-231000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	40000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-342000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	252000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	283000	USD
	us-gaap	Depreciation Depreciation	267000	USD
	us-gaap	Depreciation Depreciation	268000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	827000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	791000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-33000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	859000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1188000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	848000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	99000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-120000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3480000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2750000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1431000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2725000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	294000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-641000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3497000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1806000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5286000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2608000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1849000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-521000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1196000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-244000	USD
	smmt	Increase Decrease In Business Combination Contingent Consideration Liability IncreaseDecreaseInBusinessCombinationContingentConsiderationLiability	0	USD
	smmt	Increase Decrease In Business Combination Contingent Consideration Liability IncreaseDecreaseInBusinessCombinationContingentConsiderationLiability	-701000	USD
	smmt	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-341000	USD
	smmt	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-342000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40140000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13861000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	371000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	247000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	111000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-371000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-358000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25081000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	579000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24504000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-40508000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10285000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2064000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-787000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63842000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12138000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21270000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21636000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-199200000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17700000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40100000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21300000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	181000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	148000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	675000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	795000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	181000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	148000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	675000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	795000	USD
CY2020Q3	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	1607000	USD
CY2019Q3	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	4228000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	7715000	USD
	us-gaap	Research And Development Arrangement Contract To Perform For Others Compensation Earned ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned	14251000	USD
CY2020Q3	smmt	Research And Development Credit ResearchAndDevelopmentCredit	2559000	USD
CY2019Q3	smmt	Research And Development Credit ResearchAndDevelopmentCredit	1841000	USD
	smmt	Research And Development Credit ResearchAndDevelopmentCredit	6900000	USD
	smmt	Research And Development Credit ResearchAndDevelopmentCredit	4855000	USD
CY2020Q3	us-gaap	Other Operating Income OtherOperatingIncome	4309000	USD
CY2019Q3	us-gaap	Other Operating Income OtherOperatingIncome	6296000	USD
	us-gaap	Other Operating Income OtherOperatingIncome	14949000	USD
	us-gaap	Other Operating Income OtherOperatingIncome	19881000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-17701000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6376000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-39255000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20045000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67232000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32099000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67227000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31632000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67232000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32099000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67227000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31632000	shares
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11974480	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4131511	shares
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19010000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19762000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2775000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2263000	USD
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5134000	USD
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	4379000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11101000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13120000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000.0	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4644835	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6070557	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	4562049	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.39
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6153343	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.31
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	679600	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.00
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3800000	USD
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1000000.0	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	361000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	244000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1188000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	848000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01

Files In Submission

Name	View Source	Status
0001599298-20-000043-index-headers.html	Edgar Link	pending
0001599298-20-000043-index.html	Edgar Link	pending
0001599298-20-000043.txt	Edgar Link	pending
0001599298-20-000043-xbrl.zip	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
smmt-20200930.htm	Edgar Link	pending
smmt-20200930.xsd	Edgar Link	pending
smmt-20200930_cal.xml	Edgar Link	unprocessable
smmt-20200930_def.xml	Edgar Link	unprocessable
smmt-20200930_htm.xml	Edgar Link	completed
smmt-20200930_lab.xml	Edgar Link	unprocessable
smmt-20200930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SMMT
Summit Therapeutics Inc. Stock $smmt

2020 Q4 Form 10-Q Financial Statement

#000159929820000043 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMMT Summit Therapeutics Inc. Stock $smmt

2020 Q4 Form 10-Q Financial Statement

#000159929820000043 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMMT
Summit Therapeutics Inc. Stock $smmt